Cargando…

A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts

For physiologically important cancer therapeutic targets, use of non-invasive imaging for therapeutic guidance and monitoring may improve outcomes for treated patients. The CXC chemokine receptor 4 (CXCR4) is overexpressed in many cancers including non-small cell lung cancer (NSCLC) and triple negat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azad, Babak Behnam, Chatterjee, Samit, Lesniak, Wojciech G., Lisok, Ala, Pullambhatla, Mrudula, Bhujwalla, Zaver M., Pomper, Martin G., Nimmagadda, Sridhar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914289/ https://www.ncbi.nlm.nih.gov/pubmed/26848769 http://dx.doi.org/10.18632/oncotarget.7111

Ejemplares similares

An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications
por: Lesniak, Wojciech G., et al.
Publicado: (2022)

A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
por: Chatterjee, Samit, et al.
Publicado: (2016)

Development of [(18)F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
por: Lesniak, Wojciech G., et al.
Publicado: (2019)

A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2011)

Enhancement of Radiotherapy with Human Mesenchymal Stem Cells Containing Gold Nanoparticles
por: Pullambhatla, Mrudula, et al.
Publicado: (2020)

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
por: Chatterjee, Samit, et al.
Publicado: (2017)

Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors
por: Ngen, Ethel J., et al.
Publicado: (2021)

A side-by-side evaluation of [(18)F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomography
por: Narayan, Athira, et al.
Publicado: (2019)

Development of prostate specific membrane antigen targeted ultrasound microbubbles using bioorthogonal chemistry
por: Zlitni, Aimen, et al.
Publicado: (2017)

Peptide-Based (68)Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
por: De Silva, Ravindra A., et al.
Publicado: (2018)

(64)Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
por: Banerjee, Sangeeta Ray, et al.
Publicado: (2014)

Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
por: Krishnamachary, Balaji, et al.
Publicado: (2012)

System-level optimization in spectroscopic photoacoustic imaging of prostate cancer
por: Wu, Yixuan, et al.
Publicado: (2022)

The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts
por: Dore-Savard, Louis, et al.
Publicado: (2016)

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
por: Bharti, Santosh K., et al.
Publicado: (2018)

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents
por: Chen, Ying, et al.
Publicado: (2022)

Hypoxia Inducible Factors Modify Collagen I Fibers in MDA-MB-231 Triple Negative Breast Cancer Xenografts()()
por: Goggins, Eibhlin, et al.
Publicado: (2017)

Heterobivalent Agents Targeting PSMA and Integrin-α(v)β(3)
por: Shallal, Hassan M., et al.
Publicado: (2014)

PD-L1 near Infrared Photoimmunotherapy of Ovarian Cancer Model
por: Jin, Jiefu, et al.
Publicado: (2022)

Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?
por: Glunde, Kristine, et al.
Publicado: (2008)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

Hypoxia theranostics of a human prostate cancer xenograft and the resulting effects on the tumor microenvironment
por: Krishnamachary, Balaji, et al.
Publicado: (2020)

Targeting Phospholipid Metabolism in Cancer
por: Cheng, Menglin, et al.
Publicado: (2016)

Degradable Dextran Nanopolymer as a Carrier for Choline Kinase (ChoK) siRNA Cancer Therapy
por: Chen, Zhihang, et al.
Publicado: (2016)

Editorial: Exploring Cancer Metabolic Reprogramming through Molecular Imaging
por: Podo, Franca, et al.
Publicado: (2017)

Challenges and Initiatives in Diversity, Equity and Inclusion in Cancer Molecular Imaging
por: Daldrup-Link, Heike E., et al.
Publicado: (2021)

A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen
por: Liu, Guanshu, et al.
Publicado: (2017)

Acid-degradable Dextran as an Image Guided siRNA Carrier for COX-2 Downregulation
por: Chen, Zhihang, et al.
Publicado: (2018)

Water and Collagen Content Are High in Pancreatic Cancer: Implications for Quantitative Metabolic Imaging
por: Penet, Marie-France, et al.
Publicado: (2021)

Bacterial Thymidine Kinase as a Non-Invasive Imaging Reporter for Mycobacterium tuberculosis in Live Animals
por: Davis, Stephanie L., et al.
Publicado: (2009)

The Tumor Microenvironment Modulates Choline and Lipid Metabolism
por: Mori, Noriko, et al.
Publicado: (2016)

Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer()()
por: Cheng, Menglin, et al.
Publicado: (2017)

Phototheranostics of CD44-positive cell populations in triple negative breast cancer
por: Jin, Jiefu, et al.
Publicado: (2016)

Engineered Fragments of the PSMA-Specific 5D3 Antibody and Their Functional Characterization
por: Novakova, Zora, et al.
Publicado: (2020)

Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies
por: Peng, Sheng-Bin, et al.
Publicado: (2016)

CXCR4-Directed Imaging in Solid Tumors
por: Werner, Rudolf A., et al.
Publicado: (2019)

COX-2 in cancer: Gordian knot or Achilles heel?
por: Stasinopoulos, Ioannis, et al.
Publicado: (2013)

CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338
por: Pollino, Serena, et al.
Publicado: (2019)

Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer
por: Litman-Zawadzka, Ala, et al.
Publicado: (2020)

Combining Optical Reporter Proteins with Different Half-lives to Detect Temporal Evolution of Hypoxia and Reoxygenation in Tumors
por: Danhier, Pierre, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7u3lg09kvg37jb8erqedkd4095